Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04878432
Title STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
Arizona Oncology Associates . Tucson Arizona 85745 United States Details
SCRI-Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Yale University School Of Medicine . New Haven Connecticut 06520 United States Details
Advent Health Orlando Orlando Florida 32803 United States Details
Uni of Massachusetts Medical Center Worcester Massachusetts 01655 United States Details
University Of Michigan . Ann Arbor Michigan 48109 United States Details
Karmanos Cancer Institute Div.of Hematology/Oncology Detroit Michigan 48201 United States Details
Tisch Hospital NYU Langone New York New York 10016 United States Details
Mount Sinai Medical Center New York New York 10029-6574 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
University Hospitals Of Cleveland Cleveland Ohio 44106 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Uni Of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Texas Oncology San Antonio USO San Antonio Texas 78240 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field